Susquehanna Fundamental Investments’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Susquehanna Fundamental Investments's DGX Position: Q4 2023 in Review
Susquehanna Fundamental Investments sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 3,125 shares — an estimated $381K sold.
Susquehanna Fundamental Investments first reported a position in DGX in Q1 2019 and held it in 15 quarters. The position peaked at $20.6M in Q4 2022. 827 funds tracked by Wall St. Rank hold DGX as of Q4 2023.
- Susquehanna Fundamental Investments reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
- Susquehanna Fundamental Investments sold 3,125 Quest Diagnostics shares in Q4 2023, an estimated $381K.
- Susquehanna Fundamental Investments first reported a position in Quest Diagnostics in Q1 2019 and held it in 15 quarters.
- Susquehanna Fundamental Investments's Quest Diagnostics position peaked at $20.6M in Q4 2022.
- 827 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.
Based on Susquehanna Fundamental Investments's 13F filing for Q4 2023, filed 14 Feb 2024.